PP-Gemcitabine & External Beam Radiation-Sarcomas

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Sarcoma
Interventions
DRUG

Gemcitabine

Starting dose: 400 mg/m2 by vein on days 1, 8, 22, 29, 43, and 50.

RADIATION

Radiation Therapy

Radiation therapy dose of 50 Gy in 25 fractions at 2.0 Gy per fraction. Radiotherapy given once daily (Monday through Friday) for 5 weeks.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT02046304 - PP-Gemcitabine & External Beam Radiation-Sarcomas | Biotech Hunter | Biotech Hunter